Investment Thesis
Firefly Neuroscience is a severely distressed software company with catastrophic profitability metrics, burning substantial cash, and showing no revenue growth. The company is unprofitable at every level (gross profit exists but operating and net losses are massive), with negative free cash flow of $6.4M annually threatening long-term viability despite adequate liquidity.
AIFF Strengths
- Positive gross margin of 63.4% indicates viable underlying unit economics at the product level
- Strong liquidity position with current ratio of 2.0x and $4.3M cash provides runway for operations
- Low leverage with debt-to-equity of 0.08x limits financial distress risk from creditors
AIFF Risks
- Revenue stagnation at $730K with zero YoY growth signals failed market traction and business model dysfunction
- Operating losses of $6.4M on revenue of $730K represent 870% negative operating margin, indicating massive overhead relative to sales
- Negative free cash flow of $6.4M annually will deplete $4.3M cash reserves within ~8 months at current burn rate, creating existential solvency risk
- Net losses of $17.4M (2,384% negative margin) suggest substantial non-operating charges or asset write-downs compounding operational problems
- Minimal insider activity (2 Form 4 filings in 90 days) suggests low management confidence or activity
Key Metrics to Watch
- Operating cash flow trend and runway to cash depletion at current burn rate
- Revenue growth rate - any stabilization or recovery from current stagnation
- Operating expense reduction and path to positive EBITDA
- Cash position and potential dilutive financing events
AIFF Financial Metrics
AIFF Profitability Ratios
AIFF Balance Sheet & Liquidity
AIFF 5-Year Financial Trend
5-Year Trend Summary: FIREFLY NEUROSCIENCE, INC.'s revenue has declined by 96% over the 5-year period, indicating business contraction. The most recent EPS of $0.03 reflects profitable operations.
AIFF Growth Metrics (YoY)
AIFF Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $33.0K | -$1.1M | $-0.20 |
| Q2 2025 | $10.0K | -$1.1M | N/A |
| Q1 2025 | $12.0K | -$1.1M | N/A |
| Q3 2024 | $23.0K | -$650.0K | N/A |
| Q2 2024 | $1.9M | $234.8K | $0.36 |
| Q1 2024 | $1.9M | -$674.0K | N/A |
| Q3 2023 | $2.0M | -$149.9K | N/A |
| Q2 2023 | $2.0M | $234.8K | $0.01 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
AIFF Capital Allocation
AIFF SEC Filings
Access official SEC EDGAR filings for FIREFLY NEUROSCIENCE, INC. (CIK: 0000803578)